3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Other neoplasm
1
Conditions
Endometrial Neoplasms
2
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Menstruation Disturbances
1
Leiomyoma
1
Endometriosis
1
Adenomyosis
1
Interventions
pembrolizumab
14
Paclitaxel
13
Carboplatin
12
Bevacizumab
7
Specimen Handling
6
Cisplatin
6
olaparib
5
Taxes
5
Fulvestrant
5
Nivolumab
4
Megestrol Acetate
4
Magnetic Resonance Spectroscopy
4
Biopsy
4
palbociclib
3
durvalumab
3
Oxaliplatin
3
Leucovorin
3
Letrozole
3
Immunoglobulin G
3
Fluorouracil
3
Doxorubicin
3
Docetaxel
3
Disulfides
3
trastuzumab deruxtecan
2
ribociclib
2
pertuzumab
2
lenvatinib
2
ipatasertib
2
dostarlimab
2
capivasertib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Hysterectomy
×
30 days
×
Clear all
NCT07622901
2026-06-03
FIT-ENDO
University of Miami
Phase NA
Recruiting
42 enrolled
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled